Biocon Staying Firm On Insulins Path, Including Glargine

 
• By Anju Ghangurde
  
Traveller
BIOCON STAYS FIRM ON PLANS FOR INSULIN GLARGINE FOR NOW
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia